Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8R74

Galectin-1 in complex with thiogalactoside derivative

Summary for 8R74
Entry DOI10.2210/pdb8r74/pdb
DescriptorGalectin-1, (2~{R},3~{R},4~{S},5~{R},6~{R})-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-4-[4-(2-oxidanyl-1,3-thiazol-4-yl)-1,2,3-triazol-1-yl]oxane-3,5-diol (3 entities in total)
Functional Keywordsgalectin, ligand, thiogalactoside derivative, sugar binding protein
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight30444.09
Authors
Hakansson, M.,Diehl, C.,Peterson, K.,Zetterberg, F.,Nilsson, U. (deposition date: 2023-11-23, release date: 2024-06-05, Last modification date: 2024-06-19)
Primary citationZetterberg, F.R.,Peterson, K.,Nilsson, U.J.,Andreasson Dahlgren, K.,Diehl, C.,Holyer, I.,Hakansson, M.,Khabut, A.,Kahl-Knutson, B.,Leffler, H.,MacKinnon, A.C.,Roper, J.A.,Slack, R.J.,Zarrizi, R.,Pedersen, A.
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer.
J.Med.Chem., 67:9374-9388, 2024
Cited by
PubMed Abstract: We have previously described a new series of selective and orally available galectin-1 inhibitors resulting in the thiazole-containing glycomimetic GB1490. Here, we show that the introduction of polar substituents to the thiazole ring results in galectin-1-specific compounds with low nM affinities. X-ray structural analysis of a new ligand-galectin-1 complex shows changes in the binding mode and ligand-protein hydrogen bond interactions compared to the GB1490-galectin-1 complex. These new high affinity ligands were further optimized with respect to affinity and ADME properties resulting in the galectin-1-selective GB1908 ( galectin-1/3 0.057/6.0 μM). In vitro GB1908 inhibited galectin-1-induced apoptosis in Jurkat cells (IC = 850 nM). Pharmacokinetic experiments in mice revealed that a dose of 30 mg/kg b.i.d. results in free levels of GB1908 in plasma over galectin-1 for 24 h. GB1908 dosed with this regimen reduced the growth of primary lung tumor LL/2 in a syngeneic mouse model.
PubMed: 38804039
DOI: 10.1021/acs.jmedchem.4c00485
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.54 Å)
Structure validation

227111

건을2024-11-06부터공개중

PDB statisticsPDBj update infoContact PDBjnumon